Breaking News Instant updates and real-time market news.

AES

AES Corp.

$13.79

0.095 (0.69%)

06:05
08/07/18
08/07
06:05
08/07/18
06:05

AES Corp. backs FY18 adjusted EPS view $1.15-$1.25, consensus $1.21

"The Company reaffirms its 2018 Adjusted EPS guidance of $1.15 to $1.25 and its average annual growth rate target of 8% to 10% through 2020. Growth in 2018 will be primarily driven by contributions from new businesses, cost savings and lower Parent interest. The Company also reaffirms its 2018 Parent Free Cash Flow expectation of $600 million to $675 million. The Company's 2018 guidance and expectations through 2020 are based on foreign currency and commodity forward curves as of June 30, 2018."

  • 07

    Aug

AES AES Corp.
$13.79

0.095 (0.69%)

05/09/18
SCOT
05/09/18
UPGRADE
SCOT
Sector Perform
AES Corp. upgraded to Sector Perform from Underperform at Scotiabank
05/16/18
BOFA
05/16/18
DOWNGRADE
BOFA
Neutral
AES Corp. downgraded to Neutral from Buy at BofA/Merrill
05/16/18
05/16/18
DOWNGRADE
Target $12

Neutral
AES Corp. downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded AES Corp. to Neutral from Buy and trimmed its price target to $12 from $13. Analyst Julien Dumoulin-Smith views shares as fairly valued following the recent rally and believes management has executed well above expectations.
07/02/18
BOFA
07/02/18
DOWNGRADE
Target $12.5
BOFA
Underperform
AES Corp. downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Jullen Dumoulin-Smith downgraded AES Corp to Underperform from Neutral and raised its price target to $12.50 from $12. The analyst believes valuation is excessive following successful strategic initiatives by management and is concerned about the difficult European backdrop, especially the treatment of Bulgarian PPAs, emerging market macro risks, and limited impact on shares from recent positive news.

TODAY'S FREE FLY STORIES

GEMP

Gemphire Therapeutics

$0.94

-0.26 (-21.67%)

08:28
06/27/19
06/27
08:28
06/27/19
08:28
Upgrade
Gemphire Therapeutics rating change  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
Esperion reaches $200M revenue-based funding agreement with Oberland Capital »

Esperion and an investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNA

CareDx

$34.68

-0.99 (-2.78%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
CareDx 'applauds' progress in Medicare immunosuppressive medication legislation »

CareDx said it,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAN

Dana

$18.38

0.74 (4.20%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Initiation
Dana initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$41.55

0.05 (0.12%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Initiation
BorgWarner initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

XLY

Consumer Discretionary Sector SPDR

$118.12

0.35 (0.30%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.80

-0.12 (-0.21%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$4.07

0.07 (1.75%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Hot Stocks
Adaptimmune CFO Adrian Rawcliffe to succeed James Noble as CEO »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BC

Brunswick

$45.29

0.2 (0.44%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$59.33

-1.3 (-2.14%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.